Moon Youngbeen

Mr. Moon Youngbeen

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MYMoon Youngbeen
Moon Youngbeen
CHCHUNGHWAN HONG
CHUNGHWAN HONG
YKYOUNG-HO KIM
YOUNG-HO KIM
JKJong K. Kim
Jong K. Kim
SYSEO-HYEON YE
SEO-HYEON YE
KHKyeong-Man Hong
Kyeong-Man Hong
The cost-effectiveness of whole exome sequencing (WES) remains controversial due to variant call variability, necessitating sensitivity and specificity evaluation. WES was performed by three companies (AA, BB, and CC) using reference standards composed of DNA from hydatidiform mole and individual blood at various ratios. Sensitivity was assessed by the detection rate of null–homozygote (N–H) alleles at expected variant allelic fractions, while false positive (FP) errors were counted for unexpected alleles. Sensitivity was approximately 20% for in-house results from BB and CC and around 5% for AA. Dynamic Read Analysis for GENomics (DRAGEN) analyses identified 1.34 to 1.71 times more variants, detecting over 96% of in-house variants, with sensitivity for common variants increasing to 5%. In-house FP errors varied significantly among companies (up to 13.97 times), while DRAGEN minimized this variation. Despite DRAGEN showing higher FP errors for BB and CC, the increased sensitivity highlights the importance of effective bioinformatic conditions. We also assessed the potential effects of target enrichment and proposed optimal cutoff values for the read depth and variant allele fraction in WES. Optimizing bioinformatic analysis based on sensitivity and specificity from reference standards can enhance variant detection and improve the clinical utility of WES.

22 July 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
MYMoon Youngbeen
Moon Youngbeen
YKYoung-Ho Kim
Young-Ho Kim
JKJong-Kwang Kim
Jong-Kwang Kim
CHCHUNGHWAN HONG
CHUNGHWAN HONG
EKEun-Kyung Kang
Eun-Kyung Kang
KHKyeong-Man Hong
Kyeong-Man Hong
Background: Although next generation sequencing (NGS) has been adopted as an essential diagnostic tool in various diseases, NGS errors have been the most serious problem in clinical implementation. Especially in cancers, low level mutations have not been easy to analyze, due to the contaminating normal cells and tumor heterozygosity. Results: In targeted NGS (T-NGS) analyses for reference-standard samples containing mixtures of homozygote H. mole DNA with blood genomic DNA at various ratios from four certified NGS service providers, large differences in the lower detection limit of variants (16.3 times, 1.51∼24.66%) and the false positive (FP) error rate (4280 times, 5.814 x 10 −4 ∼1.359 x 10 −7 ) were found. Employment of the commercially available Dragen system for bioinformatic analyses reduced FP errors in the results from companies BB and CC, but the errors originating from the NGS raw data persisted. Bioinformatic conditional adjustment to increase sensitivity (less than 2 times) led to a much higher FP error rate (610∼8200 times). In addition, problems such as biased preferential reference base calls during bioinformatic analysis and high-rate FN errors in HLA regions were found in the NGS analysis. Conclusion: T-NGS results from certified NGS service providers can be quite various in their sensitivity and FP error rate, suggesting the necessity of further quality controls for clinical implementation of T-NGS. The present study also suggests that mixtures of homozygote and heterozygote DNAs can be easily employed as excellent reference-standard materials for quality control of T-NGS.

27 January 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
MYMoon Youngbeen
Moon Youngbeen
CHCHUNGHWAN HONG
CHUNGHWAN HONG
JKJong K. Kim
Jong K. Kim
EKEun kyung Kang
Eun kyung Kang
HCHye Won Choi
Hye Won Choi
KHKyeong-Man Hong
Kyeong-Man Hong
Background: We previously developed a benchmarking strategy using mixtures of homozygote and heterozygote DNAs as reference standards to simultaneously assess sensitivity and false positive (FP) error rates in targeted next-generation sequencing (T-NGS) and whole-exome sequencing (WES), revealing substantial variability across commercial platforms. However, optimal analytic conditions for clinical application remain undefined. Methods: We systematically evaluated multiple sequencing kits and bioinformatics pipelines across various variant allele fraction (VAF) thresholds to identify conditions that maximize both sensitivity and specificity. Recurrent error-prone alleles were defined and filtered to enhance specificity. Results: Optimal performance was achieved using the DRAGEN pipeline with recurrent FP allele filtering. For T-NGS, a 1% VAF cutoff yielded a 95% detection threshold of 2.99% and 1.21 FPs per megabase (FP/Mb); for WES, a 2% cutoff yielded a 95% threshold of 5.02% and 1.15 FP/Mb. These settings improved sensitivity >3-fold and reduced FP rates >96% versus suboptimal pipelines. Notably, VAF thresholds flattened sensitivity differences across platforms, obscuring key performance disparities—challenging assumptions that T-NGS is inherently more sensitive than WES. In-house and conventional pipelines undercalled up to 10% of true variants. Restricting reporting of 1–4% VAF variants to ∼1,000 predefined actionable sites enabled recovery of clinically relevant mutations while reducing FP risk >99%. Conclusions: This study provides a quantitative framework for optimizing NGS performance. Our findings support actionable strategies to improve diagnostic accuracy in clinical genomics through tailored pipeline selection, VAF thresholding, and artifact filtering.

16 September 2026 in npj Precision Oncology
Verified
Journal Article
Open access
PDF file
YKYoo-Na Kim
Yoo-Na Kim
MYMoon Youngbeen
Moon Youngbeen
SLSeo-Young Lee
Seo-Young Lee
ECEun Hye Choi
Eun Hye Choi
DHDong-Jin Han
Dong-Jin Han
ENEun Ji Nam
Eun Ji Nam
We investigated the molecular processes underlying the clinical spectrum of Lynch syndrome (LS)-associated endometrial disease using integrated genomic and transcriptomic profiling of endometrial tissues. Whole-transcriptome sequencing revealed distinct patterns of immune remodeling across clinically defined disease states (unaffected carrier, premalignant, and malignant states), characterized by increasing infiltration of T cells, particularly CD8+ subsets and B cells. Non-negative matrix factorization of transcriptomic profiles identified two cancer-associated features and one feature enriched in normal endometrium, with validation in external datasets. A dominant cancer-associated feature was characterized by immune activation, effector T-cells, and exhaustion-associated CD8+ T-cell transcriptional signatures, consistent with an immune-active microenvironment. Whole-exome sequencing identified oncogenic mutations and mismatch repair deficiency –associated mutational signatures in premalignant lesions, suggesting that these alterations are already detectable in premalignant lesions within the LS disease spectrum. Together, these findings suggest distinct immune and genomic alterations across the clinical spectrum of LS-associated endometrial disease, providing molecular insights that may inform future biomarker development and prevention-oriented studies in high-risk individuals.

Verified
Journal Article
Open access
PDF file
MYMoon Youngbeen
Moon Youngbeen
HCHye Won Choi
Hye Won Choi
EKEun kyung Kang
Eun kyung Kang
JKJong K. Kim
Jong K. Kim
SPSooyong Park
Sooyong Park
KHKyeong-Man Hong
Kyeong-Man Hong
Genomic datasets generated using hg19 and hg38 are frequently integrated by coordinate liftover, but the correctability of associated discrepancies remains uncertain. We evaluated reciprocal liftover using experimentally validated allele pairs derived from homozygote hydatidiform mole DNA, heterozygote blood DNA, and seven physical dilution mixtures. Identical whole-exome sequencing FASTQ datasets were independently analyzed against hg19 and hg38 using DRAGEN v4.3, followed by reciprocal liftover and allele-pair comparison. Discordance occurred in 789/20,038 (3.94%) and 524/19,771 (2.65%) allele pairs for hg38→19 and hg19→38, respectively. Comprehensive reanalysis incorporating intronic variants identified 304 and 156 exon-to-intronic functional shifts, substantially reducing apparent null-null (N-N) shifts. Genotype flipping and functional-region shifts accounted for 722 (91.51%) and 404 (77.10%) of discordant allele pairs in the hg38→19 and hg19→38 comparisons, respectively, and were considered potentially correctable. Residual uncorrectable discrepancies comprised 67 and 120 allele pairs (0.33% and 0.61% of all informative allele pairs, respectively), including 35 and 83 N-N shifts. BAM-level inspection revealed heterogeneous discrepancies potentially involving reference-dependent alignment, local sequence representation, and variant-calling differences. These findings demonstrate that comprehensive variant harmonization can resolve many apparent cross-assembly discrepancies, although some remain unresolved. Reanalysis against a common reference assembly remains preferable when raw sequencing data are available.